Nordea Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Sell
292,200
-12,000
-4% -$175K ﹤0.01% 631
2025
Q4
$4.82M Sell
304,200
-54,900
-15% -$778K ﹤0.01% 594
2025
Q3
$4.03M Buy
359,100
+4,100
+1% +$44.8K ﹤0.01% 636
2025
Q2
$3.12M Buy
355,000
+5,400
+2% +$43.3K ﹤0.01% 650
2025
Q1
$2.81M Buy
349,600
+11,000
+3% +$89.1K ﹤0.01% 639
2024
Q4
$3.05M Buy
338,600
+1,000
+0.3% +$8.16K ﹤0.01% 620
2024
Q3
$2.5M Sell
337,600
-12,300
-4% -$76.3K ﹤0.01% 654
2024
Q2
$1.95M Buy
349,900
+41,400
+13% +$218K ﹤0.01% 702
2024
Q1
$1.55M Buy
308,500
+105,100
+52% +$713K ﹤0.01% 749
2023
Q4
$1.86M Sell
203,400
-11,100
-5% -$91.4K ﹤0.01% 723
2023
Q3
$1.69M Buy
214,500
+2,100
+1% +$20.5K ﹤0.01% 723
2023
Q2
$2.12M Buy
+212,400
New +$2.2M ﹤0.01% 690

Other funds holding AUPH